找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Needs and Feasibility; A Guide for Engineer Caroline Baillie,Eric Feinblatt,Emily Berrington Book 2010 Springer Nature Switzerland AG 2010

[復(fù)制鏈接]
樓主: FAD
21#
發(fā)表于 2025-3-25 05:51:01 | 只看該作者
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonng β2 agonists, which are effective in the majority of patients with asthma. However, therapeutic responses to these agents vary. Severe asthma is characterized by uncontrolled symptoms and recurrent exacerbation with excessive chronic airway inflammation despite adequate and even maximum treatment
22#
發(fā)表于 2025-3-25 10:59:38 | 只看該作者
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonion of severe asthma, predict efficacy of specific therapies, and assess medication response. Pulmonary function testing is an essential biomarker for the diagnosis and management of asthma. Recently, spirometric parameters reflecting small-airway obstruction have shown promise in the diagnosis and
23#
發(fā)表于 2025-3-25 13:15:20 | 只看該作者
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonular, cellular, morphological, functional, and clinical features. This concept of the disease is particularly important for severe asthma, which is also extremely heterogeneous and accounts for a significant proportion of health-care expenditure of asthma, because it may enable us to develop safe an
24#
發(fā)表于 2025-3-25 17:22:04 | 只看該作者
25#
發(fā)表于 2025-3-25 23:18:07 | 只看該作者
Caroline Baillie,Eric Feinblatt,Thimothy Thamae,Emily Berringtonng β2 agonists, which are effective in the majority of patients with asthma. However, therapeutic responses to these agents vary. Severe asthma is characterized by uncontrolled symptoms and recurrent exacerbation with excessive chronic airway inflammation despite adequate and even maximum treatment
26#
發(fā)表于 2025-3-26 02:39:12 | 只看該作者
27#
發(fā)表于 2025-3-26 04:18:01 | 只看該作者
es, and the mainstay of therapy for this population remains inhaled corticosteroids with the addition of another controller medication. The preferred additional controller medication in older (school-age) children and adolescents is long-acting beta-agonist (LABA) delivered in a combination device,
28#
發(fā)表于 2025-3-26 11:47:00 | 只看該作者
29#
發(fā)表于 2025-3-26 13:52:00 | 只看該作者
Assessing the Need in Lesotho,facilitated by Waste for Life. We selected to work in Lesotho because the key researcher in our laboratory at Queens in Canada was from there (Thimothy Thamae), and he suggested that the materials and process would be very beneficial for his country. Before embarking on such a project we knew we had
30#
發(fā)表于 2025-3-26 17:29:45 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 23:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
钟山县| 阿巴嘎旗| 吴忠市| 京山县| 和政县| 会理县| 格尔木市| 天祝| 离岛区| 西乌珠穆沁旗| 聊城市| 常熟市| 武穴市| 清新县| 盐池县| 武清区| 准格尔旗| 海原县| 都兰县| 孝昌县| 禹州市| 湖南省| 济阳县| 阳城县| 清流县| 西和县| 巴林左旗| 古田县| 通城县| 芜湖县| 昌平区| 威信县| 二连浩特市| 平乐县| 正镶白旗| 宁都县| 镇赉县| 蒲江县| 沁源县| 阳东县| 长宁县|